In agreement with recently published studies on sporadic AD [10, 26, 27] and familial AD (FAD) [28], we found increased plasma NfL concentrations in AD patients in the dementia stage (ADD) as well as in MCI subjects with a high probability of underlying AD pathology (MCI-AD), compared with nondemented controls. Here, NEFL is linked to familial Alzheimer disease.